A Women's Health feature argues that the "food noise" GLP-1 medications are praised for silencing is not always something worth eliminating. The piece quotes three clinicians who work with disordered eating and makes a case that a quieter head around food can hide a body that is not getting enough.

Food noise, as the article defines it, is not ordinary hunger or the occasional craving. Psychotherapist Amanda Marks, LPC, LMHC, describes it as persistent, repetitive thoughts about food, eating, or body concerns that feel difficult to ignore, and the drugs involved, sold as Ozempic, Wegovy and Zepbound, mimic a hormone that signals fullness in the brain and interrupt that network.

What the numbers show

One 2026 study in a mostly white female population found a link between GLP-1 use and a reduction of more than 50 percent in the self-reported frequency, intrusiveness and disruption of food noise over about four months. A 2026 narrative review cited in the piece suggests the medications could potentially regulate brain processes involved in obsessive food thoughts, though the review's authors say more rigorous work is needed to establish whether the drugs directly cause those changes.

When silence is the symptom

The more interesting argument is the reframing. In eating disorder medicine, intrusive food thoughts are read as a biological response to restriction and undernutrition, and the Minnesota Starvation Experiment documented food preoccupation, obsessive thinking and reduced focus in healthy men during wartime restriction.

Whitney Trotter, DNP, RDN, says her first clinical question about constant food thoughts is never how to stop them but what they say about what a person's body needs. Her concern, stated plainly in the piece, is that a normal biological experience is being pathologized.

Who is taking them

A 2026 study of people with eating disorders, again mostly white and female, found nearly a quarter reported current GLP-1 use and almost a third had used one at some point, with 10 percent reporting misuse. The article notes that Layla Taylor of The Secret Lives of Mormon Wives has spoken publicly about misusing GLP-1 medications to fuel her anorexia.

Bottom line

The clinicians quoted are not arguing against the drugs. They are arguing that muted appetite makes undernutrition harder to spot, and that monitoring labs, weight trends, mood and menstrual health matters more, not less, once the noise goes quiet.